Industry-leading Clinical
Evidence in SCS

The Most Robust Body of Clinical Evidence

No other company has committed so fully to establishing clinical evidence for the safety and efficacy of a spinal cord stimulation (SCS) system with large-scale randomized clinical trials (RCTs) targeting indication expansion.

Durable Relief for Back and Leg Pain

The landmark SENZA-RCT² demonstrated long-term safety and improved efficacy for both back and leg pain with 10 kHz Therapy.

Long-Term Responder Rates

Reproducible Real-World Outcomes

In a real-world study3, chronic back pain patients achieved a 74% responder rate, mirroring the excellent outcomes of the SENZA-RCT.

Responder Rate vs.
CMM Arm at 6 Months

(≥ 50% relief)

Demonstrated Pain Relief for PDN

The SENZA-PDN, a large multi-center RCT, shows meaningful long-term pain relief with 10 kHz Therapy4.

Durable Outcomes for Non-Surgical Back Pain Patients

The SENZA-NSRBP RCT, shows substantial pain relief outcomes with 10 kHz Therapy in comparison to CMM5.